VANGUARD GROUP INC 13D and 13G filings for Fulcrum Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-03-26 6:37 pm Sale | 2026-03-13 | 13G | FULCRUM THERAPEUTICS INC FULC | VANGUARD GROUP INC | 0 0.000% | -3,274,592 (Position Closed) | Filing |
| 2024-11-12 3:51 pm Unchanged | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | VANGUARD GROUP INC | 3,274,592 5.240% | 0 (Unchanged) | Filing |
| 2024-11-04 11:49 am Purchase | 2024-09-30 | 13G | FULCRUM THERAPEUTICS INC FULC | VANGUARD GROUP INC | 3,274,592 5.240% | 3,274,592 (New Position) | Filing |